EMBC

Embecta Corp.
  • Healthcare
  • Medical - Instruments & Supplies
  • $293M market cap
Forecast run · Sep 14, 2026Upside rank 687 of 3,136

Model Signal

ForecastQ Daily Probabilities
51.4%
38.5%
37.6%

Analyst Consensus

Recommendation3.50/5 Hold
Last price$4.94
Price target$5.00
Implied move+1.2%
Analysts4

ForecastQ Portfolios

EMBC is not in any ForecastQ portfolio today. The model scores it with every run; the names it picked are in Portfolios.

Company Profile

Embecta Corp. is a medical technology enterprise devoted to enhancing the quality of life and health outcomes for individuals living with diabetes. Its comprehensive product portfolio includes essential tools such as pen needles, syringes, and advanced safety devices. Additionally, the company provides innovative digital applications designed to support patients in effectively managing their condition. Embecta distributes its offerings primarily through a network of wholesalers and distributors, reaching markets both domestically within the United States and across the globe. Established in 1924, Embecta's headquarters are located in Parsippany, New Jersey. The company transitioned to an independent entity from Becton, Dickinson and Company on April 1, 2022.

ForecastQ

Quantitative stocks signals powered by AI


The information provided is for educational purposes only and should not be considered financial advice. Past performance is not indicative of future results. ForecastQ is a research platform, a living documentation of an engineering experiment. We are not financial advisors.


© ForecastQ. All rights reserved.